SAMUEL GEORGE A. III (General Counsel/Secretary) purchased 208.8% of their position (15K shares) of LINEAGE CELL THERAPEUTICS, INC. on the open market
Open‑market purchase worth $9.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/26/2024ACC: 0000950170-24-131093
Officer· General Counsel/Secretary
Since Sep 2021
+15K
Net shares
Net buyer
$9.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
15K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+15K
Price / share
$0.60
Trade value
$9K
% of position
208.8%
11/26/2024
7.18K→22.18K
Total
Net shares
+15K
Net value
$9K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 11/26/2024 | P · Purchase | +15K | $0.60 | $9K | 208.8% | 7.18K | 22.18K |
| Total | +15K | $9K | ||||||
Derivative Transactions0
No derivative transactions reported